Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Regional Development: Finding the substance behind the smoke: Who is using biotechnology?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Burke, J.F. and Thomas, S.M. 1977. Nature Biotechnology 15: 695–696.

    Article  Google Scholar 

  2. Rose, A. 1998. Biotechnology use in Canadian Industry—1996. Statistics Canada, Tunney's Pasture, Ottawa, Canada. ST-98-05.

    Google Scholar 

  3. A small percentage of the respondent firms (6.2%) had sales in 1996 below $5 million

  4. These eight technologies are: recombinant DNA, gene probes, DNA amplification, tissue culture, somatic embryogenesis, classical and traditional breeding, bioprocessing (fermentation and recovery), and biosensing.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arunde, A., Rose, A. Regional Development: Finding the substance behind the smoke: Who is using biotechnology?. Nat Biotechnol 16, 596–597 (1998). https://doi.org/10.1038/nbt0798-596

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0798-596

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing